Potentially harmful effects of irradiation on the developing central nervous system have been well documented. We report 2 pediatric patients with moyamoya syndrome developed after irradiation. Case: A 3-year-old girl had received 4,860 cGy of postoperative radiation for optic pathway glioma. Cerebral angiography 7 months after completion of the radiation therapy revealed progressive cerebral arterial occlusive disease, involving the internal carotid artery on either side of the circle of Willis, with abnormal netlike vessels. Another 5-year-old girl had received 3,600 cGy of postoperative radiation on the cerebrum for a medulloblastoma. Two years later, she was diagnosed with moyamoya syndrome and treated with indirect revascularization. She died due to further progressive obstruction of the right M1 and A1 on the unoperated hemisphere, in spite of well-developed collateral circulation from the superficial temporal artery and middle meningeal artery on the operated left hemisphere. We suggest that radiation therapy with portals typically including carotid siphon may particularly cause vascular damage, regardless of the tumor pathology and lead to radiation-induced moyamoya syndrome. The prognosis may be poorer in case of poor collateral flow and rapid progression. The radiation therapy may cause fatal vascular damage so it should be taken into consideration when a treatment plan is being formulated for young patients.

Keywords:
Moyamoya syndrome, Radiation therapy
1.
Suzuki J, Takaku A: Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–299.
2.
Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M: Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg 1991;75:267–270.
3.
Masuda J, Ogata J, Yutani C: Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 1993;24:1960–1967.
4.
al-Amro A, Schultz H: Moyamoya vasculopathy after cranial irradiation – a case report. Acta Oncol 1995;34:261–263.
5.
Fajardo LF: Basic mechanisms and general morphology of radiation injury. Semin Roentgenol 1993;28:297–302.
6.
Zidar N, Ferluga D, Hvala A, Popovic M, Soba E: Contribution to the pathogenesis of radiation-induced injury to large arteries. J Laryngol Otol 1997;111:988–990.
7.
Bitzer M, Topka H: Progressive cerebral occlusive disease after radiation therapy. Stroke 1995;26:131–136.
8.
Ganry O, Habrand JL, Lemerle J, Flamant F, Sarrazin D: Arterial lesions after radiotherapy in children. Apropos of 16 cases. Arch Fr Pediatr 1993;50:9–14.
9.
Kyoi K, Kirino Y, Sakaki T, Tsunoda S, Hashimoto H, Hiramatsu K, Utsumi S: Therapeutic irradiation of brain tumor and cerebrovasculopathy. No Shinkei Geka 1989;17:163–170.
10.
Fukui M, Kono S, Sueishi K, Ikezaki K: Moyamoya disease. Neuropathology 2000;20(suppl):S61–S64.
11.
Hirata Y, Matsukado Y, Mihara Y, Kochi M, Sonoda H, Fukumura A: Occlusion of the internal carotid artery after radiation therapy for the chiasmal lesion. Acta Neurochir (Wien) 1985;74:141–147.
12.
Okuno T, Prensky AL, Gado M: The moyamoya syndrome associated with irradiation of an optic glioma in children: report of two cases and review of the literature. Pediatr Neurol 1985;1:311–316.
13.
Maruyama K, Mishima K, Saito N, Fujimaki T, Sasaki T, Kirino T: Radiation-induced aneurysm and moyamoya vessels presenting with subarachnoid haemorrhage. Acta Neurochir (Wien) 2000;142:139–143.
14.
Kestle JR, Hoffman HJ, Mock AR: Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 1993;79:32–35.
15.
Kurokawa T, Tomita S, Ueda K, Narazaki O, Hanai T, Hasuo K, Matsushima T, Kitamura K: Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol 1985;1:274–277.
16.
Bruno A, Adams HP Jr, Biller J, Rezai K, Cornell S, Aschenbrener CA: Cerebral infarction due to moyamoya disease in young adults. Stroke 1988;19:826–833.
17.
Takanashi J, Sugita K, Ishii M, Tanabe Y, Ito C, Date H, Niimi H: Moyamoya syndrome in young children: MR comparison with adult onset. AJNR Am J Neuroradiol 1993;14:1139–1143.
18.
Amine AR, Moody RA, Meeks W: Bilateral temporal-middle cerebral artery anastomosis for moyamoya syndrome. Surg Neurol 1977;8:3–6.
19.
Karasawa J, Kikuchi H, Furuse S, Sakaki T, Yoshida Y: A surgical treatment of ‘moyamoya’ disease ‘encephalo-myo synangiosis’. Neurol Med Chir (Tokyo) 1977;17:29–37.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.